Sp1264

NOVEL STARCH-BASED POLYSACCHARIDE SUBMUCOSAL INJECTION SOLUTION RESULTS IN DECREASED BLEEDING AND ADVERSE EVENTS IN EMR AND ESD

Date
May 18, 2024


Tracks

Related Products

Thumbnail for NOVEL STARCH-BASED POLYSACCHARIDE SUBMUCOSAL INJECTION SOLUTION RESULTS IN DECREASED BLEEDING AND ADVERSE EVENTS IN EMR AND ESD.
NOVEL STARCH-BASED POLYSACCHARIDE SUBMUCOSAL INJECTION SOLUTION RESULTS IN DECREASED BLEEDING AND ADVERSE EVENTS IN EMR AND ESD.
In Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD), submucosal lifting agents optimize safety and successful removal of target lesions. Crystalloid-oil emulsion solutions (COES) have been used in place of saline injection but have potential for peri-procedural bleeding…
Thumbnail for ASGE Presidential Plenary
ASGE Presidential Plenary
MULTICENTER PILOT RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFICACY OF THE PRIMARY OBESITY SURGERY ENDOLUMINAL (POSE2…